yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News
Cloud Expo & Virtualization 2009 East
Smarter Business Solutions Through Dynamic Infrastructure
Smarter Insights: How the CIO Becomes a Hero Again
Windows Azure
Why VDI?
Maximizing the Business Value of Virtualization in Enterprise and Cloud Computing Environments
Messaging in the Cloud - Email, SMS and Voice
Freedom OSS
Stairway to the Cloud
Sun's Incubation Platform: Helping Startups Serve the Enterprise
Cloud Computing & Enterprise IT: Cost & Operational Benefits
How and Why is a Flexible IT Infrastructure the Key To the Future?
Click For 2008 West
Event Webcasts
QxMD Adapts Scientific Papers into Interactive Clinical Decision Support Tools

QxMD Software Inc., a digital learning technology company that makes it easier for healthcare professionals (HCPs) to discover and apply the latest evidence for use in clinical practice, today announced the availability of its newest point-of-care clinical tool ‘International IgA Nephropathy Prediction Tool’ for Calculate by QxMD mobile and web app users. Coinciding with the JAMA Internal Medicine e-publication of the paper ‘Evaluating a New International Risk-Prediction Tool in IgA Nephropathy’ by Sean J. Barbour, MD, MSc, Rosanna Coppo, MD, FERA, Hong Zhang, MD, PhD, and others, the Internal IgAN Prediction Tool becomes the fourth Calculate by QxMD tool to simultaneously publish with a peer-reviewed paper or presentation since October 2018. The tool was also timed to go live at the moment Dr Barbour presented at the 2019 ISN World Congress of Nephrology in Melbourne.

This press release features multimedia. View the full release here:

International IgAN Prediction Tool on QxMD (Photo: Business Wire)

International IgAN Prediction Tool on QxMD (Photo: Business Wire)

“The QxMD publication tactic to include interactive calculators and tools at the time of publication is a winning proposition for all stakeholders, and an important strategy to achieve rapid knowledge translation,” said QxMD CEO and Medical Director Daniel Schwartz, MD, FRCPC. “Authors and affiliated organizations benefit from augmented reach and impact for their research results. Publishers benefit from additional publication brand visibility. Most importantly, patient populations benefit from healthcare providers’ ability to access resources that enhance early disease detection and diagnosis, medical intervention, and therapeutic treatment optimization.”

The IgA Nephropathy Prediction Tool accurately predicts the long-term risk of worsening kidney function at the time of kidney biopsy diagnosis of IgA nephropathy – measured as a 50% reduction in kidney function (eGFR) or the development of end-stage kidney disease. Developed by members of the International IgAN Network who analyzed data from a large number of adults with IgA nephropathy from around the world, the IgAN Prediction Tool is most reliable in predicting the risk of kidney function decline up to 5 years after kidney biopsy.

“IgA nephropathy is a highly variable condition, and patients who have IgA nephropathy and the health professionals who support them have always wanted a more accurate way of predicting future renal function decline,” added Sean Barbour, MD, M.Sc., FRCPC, the study’s lead author and assistant Professor, Division of Nephrology, Department of Medicine, Faculty of Medicine, UBC. "With our International IgAN Prediction Tool freely available on QxMD, it can be incorporated into regular care planning and point-of-care engagement for patients with IgA nephropathy. This is a major breakthrough and delivers on a key part of our knowledge translation strategy since the beginning of this project.”

Calculate by QxMD is one of many free medical apps (Read by QxMD, Learn by QxMD) that comprise the QxMD Pathways platform. Together, these apps provide millions of users with fast access to full-text research, continuing medical education (CME), and up-to-date tools that drive disease recognition and therapy optimization. Powered by a sophisticated personalization engine, the platform aggregates PubMed feeds, journal table of contents (TOCs), 450+ diagnostic tools, micro-learning CME courses and more.

QxMD has a consistent history of publishing tools on Calculate by QxMD simultaneously at the time of publication in a peer-reviewed paper or at a conference presentation. The three most recent tools, VQI Same-Day Discharge (October 2018), CLL Ball Score (November 2018) and ROKS 2018 (December 2018), were quickly used by thousands of global clinicians shortly after publication. In addition to the Calculate by QxMD publication tactic, QxMD also offers authors, publishers, and professionals in publications and medical communications the ability to transparently sponsor and disseminate research on the QxMD platform for greater publication reach and share-of-voice.

To learn more about QxMD, please visit

About QxMD
QxMD™ is a digital learning technology company that makes it easier for healthcare professionals (HCPs) to discover the latest evidence and decision support tools for use in clinical practice. The company’s HCP engagement platform comprises a library of trusted apps that provide millions of members with fast access to full-text research, continuing medical education (CME), and up-to-date tools that drive disease recognition and therapy optimization. Powered by a sophisticated personalization engine, the platform aggregates PubMed feeds, journal table of contents (TOCs), 450+ diagnostic tools, micro-CME courses & more. QxMD also serves other healthcare constituents such as hospitals, libraries, scholarly publishers, and nearly 50% of the world’s top-25 pharmaceutical companies.

About Business Wire
Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Cloud Developer Stories
Atmosera delivers modern cloud services that maximize the advantages of cloud-based infrastructures. Offering private, hybrid, and public cloud solutions, Atmosera works closely with customers to engineer, deploy, and operate cloud architectures with advanced services that delive...
In his session at 23rd International CloudEXPO, Raju Shreewastava, founder of Big Data Trunk, will provide a fun and simple way to introduce Machine Leaning to anyone and everyone. Together we will solve a machine learning problem and find an easy way to be able to do machine lea...
CloudEXPO has been the M&A capital for Cloud companies for more than a decade with memorable acquisition news stories which came out of CloudEXPO expo floor. DevOpsSUMMIT New York faculty member Greg Bledsoe shared his views on IBM's Red Hat acquisition live from NASDAQ floor. Ac...
ShieldX's CEO and Founder, Ratinder Ahuja, believes that traditional security solutions are not designed to be effective in the cloud. The role of Data Loss Prevention must evolve in order to combat the challenges of changing infrastructure associated with modernized cloud enviro...
Intel is an American multinational corporation and technology company headquartered in Santa Clara, California, in the Silicon Valley. It is the world's second largest and second highest valued semiconductor chip maker based on revenue after being overtaken by Samsung, and is the...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)!

Advertise on this site! Contact advertising(at)! 201 802-3021

SYS-CON Featured Whitepapers
Most Read This Week